Ondansetron Orally Disintegrating Tablets, USP 8 mg - NDC - 30s Bottle Label. Ondansetron Orally Disintegrating Tablets, USP 16 mg - NDC - 30s Bottle Label. Ondansetron Orally Disintegrating Tablets, USP 24 mg - NDC - 30s Bottle Label
The recommended oral dosage is one 8-mg ondansetron tablet USP or one 8-mg ondansetron orally disintegrating tablet USP given 3 times a day. For total body irradiation, one 8-mg ondansetron tablet USP or one 8-mg ondansetron orally disintegrating tablet USP should be administered 1 to 2 hours before each fraction of radiotherapy administered
Ondansetron tablet 8 mg also contains polysorbate 80 and iron oxide yellow. Each 4 mg ondansetron orally disintegrating tablet for oral administration contains 4 mg ondansetron, USP. Each 8 mg ondansetron orally disintegrating tablet for oral administration contains 8 mg ondansetron, USP.
Ondansetron Hydrochloride Tablets and Ondansetron Orally Ondansetron Orally Disintegrating Tablets (ODT) USP, 4 mg and 8 mg.
Ondansetron Orally Disintegrating tablets USP 8 mg. 2. Qualitative and quantitative composition: Each Uncoated tablet contains: Ondansetron USP 8 mg.
Ondansetron Orally Disintegrating tablets USP 8 mg. 2. Qualitative and quantitative composition: Each Uncoated tablet contains: Ondansetron USP 8 mg.
ZOFRAN. ODT. (Oral Disintegrating Tablets). (ondansetron). 4 mg and 8 mg ondansetron orally disintegrating tablets, USP. Antiemetic. (5-HT3
Each 4 mg ondansetron orally disintegrating tablet, USP for oral administration contains 4 mg ondansetron base. Each 8 mg ondansetron orally disintegrating tablet
Ondansetron Orally Disintegrating tablets USP 8 mg. 2. Qualitative and quantitative composition: Each Uncoated tablet contains: Ondansetron USP 8 mg.
Comments
MG